◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Arch Biopartners Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 299,832 226,912 364,652 255,593 250,418 --
General And Administrative Expense 298,502 225,702 288,519 251,257 246,720 --
Research And Development -283,505 90,267 105,535 78,185 365,571 --
Other Operating Expenses 200,588 -100,725 50,959 -46,612 415,484 --
Operating Expense 216,915 216,454 521,146 287,166 1.0M --
Operating Income -216,915 -216,454 -521,146 -287,166 -1.0M --
EBIT -207,472 -183,460 -557,532 -346,150 -987,226 --
Interest Expense 62,286 58,874 66,821 70,151 116,730 --
Interest Expense Non Operating 62,286 58,874 66,821 70,151 116,730 --
Interest Income 0.00 0.00 0.00 -- 0.00 0.00
Interest Income Non Operating 0.00 0.00 0.00 -- 0.00 0.00
Net Interest Income -62,286 -58,874 -66,821 -70,151 -116,730 --
Other Income Expense 9,443 32,994 -36,386 -58,984 44,247 --
Gain On Sale Of Security 9,443 32,994 -36,386 -58,984 37,438 --
Pretax Income -269,758 -242,334 -624,353 -416,301 -1.1M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -269,758 -242,334 -624,353 -416,301 -1.1M --
Net Income From Continuing Operation Net Minority Interest -269,758 -242,334 -624,353 -416,301 -1.1M --
Net Income Including Noncontrolling Interests -269,758 -242,334 -624,353 -416,301 -1.1M --
Net Income Common Stockholders -269,758 -242,334 -624,353 -416,301 -1.1M --
Net Income -269,758 -242,334 -624,353 -416,301 -1.1M --
EBITDA -207,472 -183,460 -557,532 -346,150 -987,226 --
Normalized EBITDA -216,915 -216,454 -521,146 -287,166 -1.0M --
Basic EPS -- -0.00 -0.01 -0.01 -- -0.01
Diluted EPS -- -0.00 -0.01 -0.01 -- -0.01
Basic Average Shares -- 66.1M 65.5M 64.9M -- 62.8M
Diluted Average Shares -- 66.1M 65.5M 64.9M -- 62.8M
Total Unusual Items 9,443 32,994 -36,386 -58,984 37,438 --
Total Unusual Items Excluding Goodwill 9,443 32,994 -36,386 -58,984 37,438 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -279,201 -275,328 -587,967 -357,317 -1.1M --
Diluted NI Availto Com Stockholders -269,758 -242,334 -624,353 -416,301 -1.1M --
Insurance And Claims 4,828 966.00 3,936 3,936 -237.00 --
Net Income Continuous Operations -269,758 -242,334 -624,353 -416,301 -1.1M --
Net Non Operating Interest Income Expense -62,286 -58,874 -66,821 -70,151 -116,730 --
Other Gand A 116,249 99,556 125,177 87,083 96,090 --
Salaries And Wages 177,425 125,180 159,406 160,238 150,867 --
Selling And Marketing Expense 1,330 1,210 76,133 4,336 3,698 --
Total Expenses 216,915 216,454 521,146 287,166 1.0M --
Total Operating Income As Reported -279,201 -275,328 -587,967 -357,317 -1.1M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 2,102 167,460 10,029 54,849 2,970 --
Cash Cash Equivalents And Short Term Investments 2,102 167,460 10,029 54,849 2,970 --
Accounts Receivable 0.00 0.00 443,576 443,576 724,673 --
Receivables 77,743 57,217 486,269 457,628 899,316 --
Prepaid Assets 24,685 41,782 53,347 21,053 33,329 --
Current Assets 104,530 266,459 549,645 533,530 935,615 --
Total Non Current Assets 0.00 0.00 0.00 0.00 0.00 --
Total Assets 104,530 266,459 549,645 533,530 935,615 --
Current Debt 2.5M 2.4M 2.4M 2.8M 2.8M --
Current Debt And Capital Lease Obligation 2.5M 2.4M 2.4M 2.8M 2.8M --
Accounts Payable 1.0M 1.3M 1.5M 1.5M 2.3M --
Payables 1.5M 1.5M 1.9M 1.9M 2.4M --
Payables And Accrued Expenses 1.5M 1.5M 1.9M 2.0M 2.4M --
Current Accrued Expenses 0.00 0.00 0.00 53,636 42,925 --
Current Deferred Revenue 0.00 0.00 0.00 0.00 117,865 --
Current Liabilities 4.0M 3.9M 4.3M 4.8M 5.3M --
Long Term Debt -- -- -- -- -- 500,000
Long Term Debt And Capital Lease Obligation -- -- -- -- -- 500,000
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 4.0M 3.9M 4.3M 4.8M 5.3M --
Common Stock 20.3M 19.2M 18.9M 17.9M 18.3M --
Capital Stock 20.3M 19.2M 18.9M 17.9M 18.3M --
Additional Paid In Capital 6.6M 7.7M 7.6M 7.6M 6.7M --
Retained Earnings -33.5M -33.3M -33.0M -32.4M -32.0M --
Common Stock Equity -3.9M -3.7M -3.8M -4.3M -4.3M --
Stockholders Equity -3.9M -3.7M -3.8M -4.3M -4.3M --
Total Equity Gross Minority Interest -3.9M -3.7M -3.8M -4.3M -4.3M --
Total Capitalization -3.9M -3.7M -3.8M -4.3M -4.3M --
Net Tangible Assets -3.9M -3.7M -3.8M -4.3M -4.3M --
Tangible Book Value -3.9M -3.7M -3.8M -4.3M -4.3M --
Working Capital -3.9M -3.7M -3.8M -4.3M -4.3M --
Invested Capital -1.4M -1.2M -1.4M -1.4M -1.6M --
Total Debt 2.5M 2.4M 2.4M 2.8M 2.8M --
Net Debt 2.5M 2.3M 2.4M 2.8M 2.8M --
Share Issued 66.1M 66.1M 65.9M 64.9M 64.7M --
Ordinary Shares Number 66.1M 66.1M 65.9M 64.9M 64.7M --
Current Deferred Liabilities 0.00 0.00 0.00 0.00 117,865 --
Current Notes Payable 2.5M 2.4M 2.4M 2.3M 2.3M --
Dueto Related Parties Current 344,851 230,857 483,143 452,346 0.00 --
Interest Payable 0.00 0.00 0.00 53,636 42,925 --
Other Current Borrowings -- -- -- 500,000 500,000 2.6M
Other Equity Interest 2.7M 2.7M 2.7M 2.7M 2.7M --
Other Payable 103,953 -- -- -- 35,531 --
Taxes Receivable 77,743 57,217 42,693 14,052 174,643 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Issuance Of Debt -230,857 0.00 -- 56,712 36,000 314,000
Repayment Of Debt -- -252,286 -- -- 175,000 -175,000
Net Issuance Payments Of Debt -230,857 -252,286 0.00 56,712 36,000 --
Issuance Of Capital Stock -14,321 296,000 506,200 446,907 427,500 --
Net Common Stock Issuance -14,321 296,000 506,200 446,907 427,500 --
Financing Cash Flow 92,542 43,714 529,821 954,934 428,867 --
Cash Flow From Continuing Financing Activities 92,542 43,714 529,821 954,934 428,867 --
Changes In Cash -165,358 157,431 -44,820 51,879 -40,977 --
Beginning Cash Position 167,460 10,029 54,849 2,970 43,947 --
End Cash Position 2,102 167,460 10,029 54,849 2,970 --
Free Cash Flow -257,900 113,717 -574,641 -903,055 -469,844 --
Cash Flowsfromusedin Operating Activities Direct -257,900 113,717 -574,641 -903,055 -469,844 --
Classesof Cash Payments -1.7M -485,159 -570,474 -1.3M -967,098 --
Classesof Cash Receiptsfrom Operating Activities 0.00 601,656 -- 441,688 340,090 346,980
Common Stock Issuance -14,321 296,000 506,200 446,907 427,500 --
Interest Paid Direct 1.4M -2,780 -4,167 -56,713 157,164 --
Interest Received Direct -- -- 0.00 -- -- --
Net Other Financing Charges -- -- 23,621 451,315 -34,633 -175,000
Net Short Term Debt Issuance -230,857 -252,286 0.00 56,712 36,000 --
Paymentsto Suppliersfor Goodsand Services -1.7M -485,159 -570,474 -1.3M -967,098 --
Receiptsfrom Government Grants 0.00 601,656 0.00 441,688 340,090 --
Short Term Debt Issuance -230,857 0.00 -- 56,712 36,000 314,000
Short Term Debt Payments -- -252,286 -- -- 175,000 -175,000
NEWS
Loading news...
TRENDING
Loading...